Venture capital funding for digital health companies grew to $9.5 billion in 2018, up 32% from $7.2 billion in 2017, according to Mercom Capital Group, a global communications and research firm.
WeHealth by Servier and Pathmaker Neurosystems have formed a partnership to develop and commercialise Pathmaker’s MyoRegulator device, a non-invasive treatment for spasticity.
Verily, an Alphabet portfolio company, has closed a $1 billion external funding round led by Silver Lake. The capital will be used to invest in strategic partnerships, in business development, and acquisitions.
Mindstrong Health has increased its Series B investment round with an additional $31 million, led by General Catalyst.
SOPHiA GENETICS has closed a $77 million funding round led by Generation Investment Management, with participation from Idinvest Partners, alongside existing investors including Balderton Capital and Alychlo.